Commercial Plant-Produced Recombinant Protein Products

<p>1 Introduction — Plant-produced protein products</p><p>Elizabeth E. Hood and Paul Christou</p><p>Part I: Highly Purified Proteins</p><p>2 Commercial Plant-Produced Recombinant Avidin</p><p>Elizabeth E. Hood and John A. Howard</p><p>3 Molecular farming in plants – the long road to the market</p><p>Rainer Fischer, Johannes F Buyel, Stefan Schillberg and Richard M Twyman</p><p>4 TrypZean™: an animal-free alternative to bovine trypsin</p><p>Aparna Krishnan, Susan L. Woodard</p><p>5 Production of Pharmaceutical Grade Recombinant Native Aprotinin and Non-Oxidized Aprotinin-Variants Under Greenhouse and Field Conditions </p><p>Gregory P. Pogue, Fakhrieh Vojdani, Kenneth E. Palmer, Earl White, Hugh Haydon, Barry Bratcher</p><p>Part II: Vaccines</p><p>6 Influenza virus-like particles produced in Nicotiana benthamiana protect against a lethal viral challenge in mice</p><p>Louis-P Vézina, Brian J Ward, Marc-André D’Aoust, Manon Couture, Sonia Trépanier, Andrew Sheldon1, Nathalie Landry</p><p>7 Plant-Produced Recombinant Transmission Blocking Vaccine Candidates to Combat Malaria</p><p>Stephen J. Streatfield, Natasha Kushnir, Vidadi Yusibov</p><p>8 An oral vaccine for TGEV immunization of pigs</p><p>Rajan, V.</p><p>9 Edible Rabies Vaccines</p><p>Elizabeth Loza-Rubio and Edith Rojas-Anaya</p><p>10 Newcastle disease vaccines</p><p>Miguel A. Gómez Lim</p><p>11 An oral vaccine for hepatitis B: challenges, setbacks, and breakthroughs</p><p>Celine A. Hayden</p><p>Part III: Industrial Proteins</p><p>12 Commercial Plant-Produced Recombinant Cellulases for Biomass Conversion</p><p>Elizabeth E. Hood, Deborah V. Requesens</p><p>13 Brazzein: A High Intensity Natural Sweetener</p><p>Gina Fake and John Howard</p><p>Part IV: Future Directions</p><p>14 The Future of Plant-Produced Pharmaceuticals and Industrial Proteins</p><p>John Howard, Elizabeth E. Hood</p><p>